Biomedical Signal Extraction From Symptom Descriptions: An Observational Registry Using the OpenGenome Platform

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorOpenGenome

About this trial

This registry prospectively collects anonymized free-text symptom descriptions submitted voluntarily by adults through the OpenGenome platform at opengenome.bio. For each submission, the system retrieves real biomedical literature from PubMed and ClinicalTrials.gov in parallel, applies a constrained reasoning model operating under a strict output schema, and returns a structured biological signal report. The study evaluates the internal consistency of extracted signals, the calibration of confidence scores relative to dataset size and symptom specificity, and the distribution of biological signal categories across a large anonymous population. No intervention is assigned. No participant contact occurs. All data is anonymized at the point of collection.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Automated or programmatically generated submissions detected by rate limiting

Submissions containing no discernible symptom or health-related content

Disqualifiers

None

Trial population

Adults aged 18 years or older who voluntarily access the OpenGenome platform at opengenome.bio and submit a free-text description of symptoms or health-related observations for automated biomedical signal analysis.

Trial design

Design model

Ecologic or community

Time perspective

Prospective

Treatments tested in this trial

  • OpenGenome AI Platform

    Other intervention

    AI-assisted biomedical signal extraction from free-text symptom descriptions, cross-referenced against PubMed and ClinicalTrials.gov evidence sources.

Treatment groups

1,000 Participants
are divided into 1 treatment group
Group A: Voluntary Submitters1 intervention

Trial outcomes

Primary outcomes

1

Internal signal-source concordance rate

Proportion of primary signal claims in generated reports that are traceable to at least one retrieved PubMed or ClinicalTrials.gov source included in the same report

Time frame
At point of automated report generation, assessed continuously over 12 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.